van der Velden Jaap J A J, Vreeburg Maaike, Smeets Eric E J, Schrander-Stumpel Constance T R M, van Steensel Maurice A M
Department of Dermatology, Maastricht University Medical Center, The Netherlands.
Int J Dermatol. 2008 Nov;47 Suppl 1:45-8. doi: 10.1111/j.1365-4632.2008.03960.x.
Cowden disease is a rare autosomal dominant disorder characterized by multiple hamartomas and (malignant) tumors affecting major organs including the breast, thyroid, endometrium, brain, skin and mucosa. Diagnostic criteria as formulated by the International Cowden Consortium serve as a guideline to clinically identify patients in which Cowden disease is suspected. However, the spectrum of abnormalities associated with PTEN mutations is very broad, such that the term PTEN hamartoma tumor syndrome (PTHS) is often used. The diagnostic criteria for Cowden disease do not always serve to reliably identify patients who fall within the PTHS spectrum. Therefore, it is important that clinicians are aware of features that should raise the suspicion of such a syndrome. To illustrate this point, we present three patients with clinical features of the PTEN hamartoma tumor syndrome spectrum. These patients have macrocephaly in common. Two of them meet the criteria for Cowden disease; one patient refused mutation analysis, while mutation analysis in the other patient revealed no PTEN mutation. The third patient does not meet the criteria for Cowden disease; however, genetic analysis showed a pathogenic mutation in the PTEN gene. Dermatologists regularly encounter the (muco-)cutaneous abnormalities that can be seen in PTEN hamartoma tumor syndrome. These findings combined with a (family) history of internal malignancy or a macrocephaly should raise the suspicion of PTHS, even in the absence of classical Cowden criteria.
考登病是一种罕见的常染色体显性遗传病,其特征为多发性错构瘤和(恶性)肿瘤,累及包括乳腺、甲状腺、子宫内膜、脑、皮肤和黏膜在内的主要器官。国际考登病联盟制定的诊断标准可作为临床识别疑似考登病患者的指南。然而,与PTEN突变相关的异常范围非常广泛,因此常使用术语PTEN错构瘤肿瘤综合征(PTHS)。考登病的诊断标准并不总是能可靠地识别出属于PTHS范围的患者。因此,临床医生了解应引起对这种综合征怀疑的特征非常重要。为说明这一点,我们介绍三位具有PTEN错构瘤肿瘤综合征谱系临床特征的患者。这些患者都有巨头症。其中两位符合考登病的标准;一位患者拒绝进行突变分析,而另一位患者的突变分析未发现PTEN突变。第三位患者不符合考登病的标准;然而,基因分析显示PTEN基因存在致病突变。皮肤科医生经常会遇到PTEN错构瘤肿瘤综合征中可见的(黏液性)皮肤异常。即使没有典型的考登病标准,这些发现结合内部恶性肿瘤家族史或巨头症,也应引起对PTHS的怀疑。